---
layout: post
title: New Drug Approvals 2014 - Pt. IV - Dapagliflozin (Farxigaâ„¢)
date: '2014-04-29T16:36:00.001+01:00'
author: Patricia
tags: 
modified_time: '2014-04-29T16:36:57.880+01:00'
thumbnail: http://1.bp.blogspot.com/-llkBErxE2NM/U1-3oNxaTGI/AAAAAAAAA1I/OtJWNlcBTNo/s72-c/Screen+Shot+2014-04-29+at+15.29.13.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-2100166789681750264
blogger_orig_url: https://www.blogger.com/comment.g?blogID=2546008714740235720&postID=2100166789681750264
---

<div class="separator" style="clear: both; text-align: center;"><a href="http://1.bp.blogspot.com/-llkBErxE2NM/U1-3oNxaTGI/AAAAAAAAA1I/OtJWNlcBTNo/s1600/Screen+Shot+2014-04-29+at+15.29.13.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://1.bp.blogspot.com/-llkBErxE2NM/U1-3oNxaTGI/AAAAAAAAA1I/OtJWNlcBTNo/s1600/Screen+Shot+2014-04-29+at+15.29.13.png" /></a></div><br />
<center face="arial"><img src="https://www.ebi.ac.uk/chembltools/autoiconlarge2/7,1,0,1,0,1,0,0,0,1" width="400" /></center><br />
<div style="text-align: center;"><b>Wikipedia: </b><a href="http://en.wikipedia.org/wiki/Dapagliflozin">Dapagliflozin</a><br />
<b>ATC code: </b><a href="http://www.whocc.no/atc_ddd_index/?code=A10BX09">A10BX09</a></div><br />
<div style="text-align: left;">On January 8th 2014, FDA approved Dapagliflozin (tradename: <a href="http://www.trademarkia.com/farxiga-86049285.html">Farxiga</a>; research code: BMS-512148; ChEMBL: <a href="https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429910">CHEMBL429910</a>), a <a href='http://en.wikipedia.org/wiki/Sodium-glucose_transport_proteins'>sodium-glucose cotransporter</a> 2 (SGLT2) inhibitor indicated to improve glycemic control, along with diet and exercise, in adults with <a href='http://en.wikipedia.org/wiki/Type_II_diabetes'>type 2 diabetes mellitus</a>. Dapagliflozin is the second SGLT2 inhibitor to reach the US market, after the first-in-class <a href='http://chembl.blogspot.co.uk/2013/04/new-drug-approvals-2013-pt-v.html'>Canagliflozin</a>. However, Dapagliflozin was the first SGLT2 inhibitor approved anywhere in the world in 2011 by EU.<br />
<br />
<br />
<br />
<br />
<br />
</div>